Abstract
Purpose
This study aimed to analyze the effect of body mass factors (BMFs) on setup errors in gynecologic tumors, and whether the planned tumor volumes (PTVs) are adequate for obese patients.
Methods
This was a retrospective study of 46 consecutive female patients with gynecologic tumors who were treated with volumetric modulated arc therapy. Setup accuracy was verified using daily cone beam computed tomography. Accuracy was determined for each fraction by testing 2 different PTVs (cutoff I = ≤0.7 cm; cutoff II = ≤1.0 cm). A pooled analysis was conducted to test the association between accuracy levels (within vs beyond PTV) and the mean and variance of body mass index (BMI), umbilical (UC), and hip circumference (HC). A receiver operating characteristics curve analysis was carried out to test the sensitivity of BMI, UC, and HC in predicting inaccurate setup.
Results
A significant association between BMFs and level of accuracy was observed in the lateral and vertical directions, but not in the longitudinal direction. In the lateral direction, inaccurate setups were associated with a greater BMI (mean difference: ∼3.50 kg/m2; P = .001), UC (∼10 cm), and HC (∼8 cm) compared with accurate setups (P < .001). With respect to the vertical direction, inaccurate setups (>0.7 cm margin [cutoff I]) were associated with a greater BMI (mean difference = 7.4 kg/m2; P = .001), UC (5.3 cm; P < .001), and HC (16.0 cm; P < .001) with reference to accurate setups. The receiver operating characteristics curve analysis showed that a BMI >31.4 kg/m2 was predictive for inaccurate setup in the vertical direction with 90.0% sensitivity with respect to cutoff I. Furthermore, a BMI >30.3 kg/m2 was predictive for inaccurate setup in the lateral direction with 92.5% sensitivity with respect to cutoff II.
Conclusions
The accuracy of radiation therapy setups for gynecologic tumors is highly sensitive to patients’ BMI, notably in the lateral and vertical directions. We suggest that daily cone beam computed tomography should be applied on patients with a BMI >30.3 kg/m2, using customized protocols that are lower in dose and comparable in image quality.
Introduction
Gynecologic tumors, including uterine, cervix, and ovarian cancers, are among the 10 most common tumors in Saudi women1 and the leading causes of lethality among women globally.2 The majority of these patients require postoperative radiation therapy (RT), notably for high-grade tumors.3,4 With advancing RT techniques, such as intensity modulated RT, a more accurate delineation of target volumes is required, emphasizing the need for accurate daily setup and immobilization to reduce setup errors.5
Guidelines set by the Radiation Therapy Oncology Group for gynecologic tumors established 2 different clinical tumor volumes (CTVs) depending on the bladder being full or empty. The volume resulting from the combination of the above 2 volumes was defined as the internal target volume.6 In a study conducted by the authors, 2 different immobilization devices for RT treatment of pelvic cancer were compared, and gynecologic tumors and obesity were determined to be associated with greater setup errors in translational directions.7 Subsequently, the authors turned their focus on gynecologic tumors to determine the magnitude of setup displacement in relation to body mass factors (BMFs) and its effect on the aforementioned target volumes.
Substantial evidence has shown that obesity represents a challenge in the RT of gynecologic cancers.8 Obese patients and patients with a large hip circumference (HC) and umbilical anterior–posterior diameter had greater setup displacements,9, 10, 11, 12, 13 because treatment requires daily imaging to ensure reproducibility of setup. Otherwise, expanding the target volumes may be necessary, especially where daily imaging is not practicable, which is the case in settings with reduced resources or high patient flow or particular circumstances, such as the coronavirus disease 2019 pandemic.14
This study analyzed the effect of 3 different BMFs, including BMI, HC, and umbilical circumference (UC), on setup errors in gynecologic tumors, attempting to determine the optimum PTV as a function of patient corpulence. The study hypothesis was that setup errors increase with BMFs, notably in the translational shifts; thus, obese women require greater margins for PTV compared with their nonobese counterparts. The following objectives were explored: Analysis of the association between setup errors and all 3 BMFs; determination of BMI, UC, and HC thresholds beyond which the used PTV margins are not compatible, and testing of the sensitivity of these thresholds.
Methods
Design and Setting
A retrospective study was conducted in the Radiation Oncology Unit. The study protocol was reviewed by the institutional review board, which provided ethical approval.
Participants
The study included data from 46 consecutive women with endometrial or cervix cancer treated with curative volumetric modulated arc therapy (VMAT), with or without surgery, between 2020 and 2021. Patients with other pelvic tumors and those treated with palliative RT were not included.
Treatment Planning
Before computed tomography (CT) simulation, all patients were given instructions to empty their bowels, and drink a fixed amount of water after emptying their bladder. Patients were in the supine position, with their head on a pillow, arms on the chest (patients with para-aortic involvement had arms above the head), and legs positioned using a low dual-leg positioner fixed to the treatment couch, with an indexing bar to minimize setup errors. An anterior–posterior tattoo and 2 lateral tattoos were placed at the level of the pubis (most stable point), using setup lasers, to facilitate daily setup reproducibility. For para-aortic involvement, an additional tattoo was placed anteriorly at the level of the inferior umbilicus. A CT scan was performed using 3-mm slice thickness. The CTV was defined per the Radiation Therapy Oncology Group guidelines, with an expansion of 0.7 cm and 1 cm for the PTVs for organ motion and setup errors.
Daily Imaging
All patients underwent a pre-RT assessment of setup accuracy in the supine position (same as in CT simulation), using daily kV cone beam CT imaging (after aligning tattoo marks on patients to lasers, and implementing shifts to isocenter per the plan). The acquired images were registered by a qualified therapist to the planning reference image to determine the corresponding translational and rotational shifts compared with the adjacent bony and soft tissues. Initial alignment was to the bone for nodal involvement, followed by a soft-tissue match for the vaginal cuff. Where the bladder or bowel was noncompliant, the patient was removed from the treatment couch, and asked to drink more water, defecate, or get rid of gas, as required. Patients were setup again afterward.
All shifts were computed by shifting the treatment couch. The shifts defined as setup errors were recorded and analyzed by systematic and random errors as described previously7 through the 6 directions (lateral, vertical, and longitudinal, and X, Y, and Z rotational axes).
Patients’ weight and height were measured to calculate the body mass index (BMI). In addition, BMI, UC, and HC were measured at baseline and the 10th and 20th fractions. Other BMFs, including umbilical anterior–posterior and lateral diameters and hip anterior–posterior and lateral diameters, were only measured at baseline. Weight was measured to the nearest 0.1 kg using an electronic scale, and the other anthropometric indices were measured on cone beam CT images to the nearest 0.1 cm. BMI was categorized as underweight (<18.5 kg/m2), normal (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2), and obese (≥30.0 kg/m2). UC and HC were analyzed as continuous variables.
Statistical Methods
The data were collected, the database was cleaned and coded, and the variables were calculated in Microsoft Excel. Descriptive and analytic statistical analyses were performed with the Statistical Package for Social Sciences, version 21.0, software for Windows (SPSS Inc; Chicago, IL). Categorical variables are presented as frequency and percentage, and continuous variables are presented as mean ± standard deviation (SD).
Average absolute shifts were calculated separately for all fractions in the translational and rotational directions for both systematic and random errors by transforming negative into positive values in the translational directions, and large values into absolute values (360-raw value) in the rotational directions. Additionally, translational and rotational total vector errors (TVEs) were estimated to determine the overall shift in the 3 translational and 3 rotational directions from the simulation isocenter, and were calculated as follows:
Linear regression was used to analyze the relationship of translational and rotational TVEs with the BMFs. The results are depicted as unstandardized regression coefficient (B) with 95% confidence interval (CI), and the goodness-of-fit measure is expressed by squared Pearson's coefficient (R2). Accuracy was determined for each fraction by testing 2 different cutoffs in translational shifts, including ≤ 0.7 cm and ≤ 1.0 cm. Accuracy rates were calculated by direction, in systematic and random settings separately, and were computed for each patient as the percentage of fraction shifts within the PTV, defined as +0.7 cm (cutoff I) and +1.0 cm (cutoff II) margins of the CTV for translational shifts and +3 for rotational shifts. The mean ± SD of accuracy rates was calculated, and bivariate intercorrelations were analyzed with respect to each translation cutoff using Pearson's correlation.
In addition to baseline measures, measures of BMI, UC, and HC were repeated at the 10th and 20th fractions for 31 and 29 of 46 patients, respectively. To analyze the correlation of accuracy in translational directions with 3 BMFs, a pooled database was generated. This pooled database was comprised of shifts of the first 20 fractions, coded as 1 for translational shifts within tye PTV (ie, accurate) and 0 for those beyond the PTV (inaccurate), along with the corresponding BMI, UC, and HC values. For patients with repeated measures, measured values of BMFs at baseline, as well as those at the 10th and 20th fractions, were matched with the corresponding shifts, and intermediate shifts (ie, fractions 2-9 and 11-19) were matched with estimated values of BMI, UC, and HC assuming a linear change between the measured values at baseline and the 10th fraction and between the 10th and 20th fractions, respectively.
For patients without repeated measures of BMFs (previous cone beam CT images not available to extract data), only the 1st fraction's data were matched with baseline measures of BMFs. Thus, the acquired database was comprised of pooled data for 3 BMFs, including BMI (n = 584), UC (n = 615), and HC (n = 615) and 2 accuracy rates with respect to the 2 PTV cutoffs (≤0.7 cm and ≤ 1.0cm) for each to the 3 translational directions, including lateral (n = 841), longitudinal (n = 841), and vertical (n = 838). An independent t test was used to compare the means and variations of the BMFs of shifts within versus those beyond the PTV.
Furthermore, a receiver operating characteristics (ROC) curve analysis was performed to analyze the validity of BMI, CU, and HU in predicting inaccurate settings (beyond PTV) in the significant directions. The data are presented as area under the curve (AUC) with standard error and 95% CI. Additionally, the best cutoff was determined by calculation of Youden's index using the ROC curve coordinate points, and the sensitivity and specificity of the determined cutoff was calculated. For all statistical tests, P < .05 was considered to reject the null hypothesis.
Results
Baseline Patient Clinical and Anthropometric Characteristics
The mean age of patients was 55.54 years (SD: 14.12 years). The majority of patients had cervix cancer (63.0%) and received a total RT dose of 45 Gy (63.0%). The mean BMI was 31.67 kg/m2 (SD: 7.71 kg/m2), with the majority being overweight (26.1%) or obese (56.6%). Other anthropometric measures are depicted in Table 1.
Table 1.
Baseline participant clinical and anthropomorphic characteristics (N = 46)
| Parameter | Mean | Standard deviation | |
|---|---|---|---|
| Age, y | 55.54 | 14.12 | |
| Height, cm | 154.51 | 6.91 | |
| Weight, kg | 75.86 | 20.10 | |
| Body mass index, kg/m2 | 31.67 | 7.71 | |
| Umbilical anterior–posterior diameter, cm | 24.41 | 4.56 | |
| Umbilical lateral diameter, cm | 35.82 | 5.45 | |
| Hip anterior–posterior diameter, cm | 23.68 | 4.47 | |
| Hip lateral diameter, cm | 37.93 | 5.84 | |
| Umbilical circumference, cm | 102.41 | 17.43 | |
| Hip circumference, cm | 108.64 | 14.17 | |
| Parameter | Category | Frequency | Percentage |
| Body mass index | Underweight (<18.5 kg/m2) | 1 | 2.2 |
| Normal (18.5-24.9 kg/m2) | 7 | 15.2 | |
| Overweight (25.0-29.9 kg/m2) | 12 | 26.1 | |
| Class I obesity (30.0-34.9 kg/m2) | 12 | 26.1 | |
| Class II obesity (35.0-39.9 kg/m2) | 9 | 19.6 | |
| Class III obesity (≥40.0 kg/m2) | 5 | 10.9 | |
| Diagnosis | Cervix | 29 | 63.0 |
| Endometrium | 17 | 37.0 | |
| Intact | 21 | 45.7 | |
| Postoperative | 25 | 54.3 | |
| Total dose, Gy | 45 | 29 | 63.0 |
| 54 | 1 | 2.2 | |
| 55 | 1 | 2.2 | |
| 57 | 15 | 32.6 | |
| Number of fractions | 25 | 46 | 100.0 |
| Dose per fraction, Gy | 1.80 | 29 | 63.0 |
| 2.16 | 1 | 2.2 | |
| 2.20 | 1 | 2.2 | |
| 2.30 | 15 | 32.6 |
Average Absolute shifts and Total Vector Errors
Translational shifts were larger and with a higher variance in lateral and longitudinal directions (mean: ≥0.45; SD: ≥0.23) compared with the vertical direction (mean: ≤0.29; SD: ≤0.16) when considering both systematic and random settings. The mean TVE was 0.86 (SD: 0.34) and 0.79 (SD: 0.30) in the systematic and random settings, respectively (Table 2).
Table 2.
Average absolute shifts and total vector errors
| Setting/plan | Direction | Mean | Standard deviation |
|---|---|---|---|
| Systematic settings | |||
| Translational | Lateral | 0.49 | 0.28 |
| Longitudinal | 0.46 | 0.32 | |
| Vertical | 0.29 | 0.16 | |
| Rotational | X | 1.32 | 0.85 |
| Y | 0.91 | 0.47 | |
| Z | 0.74 | 0.39 | |
| Random settings | |||
| Translational | Lateral | 0.46 | 0.23 |
| Longitudinal | 0.45 | 0.23 | |
| Vertical | 0.24 | 0.09 | |
| Rotational | X | 1.26 | 0.55 |
| Y | 0.86 | 0.35 | |
| Z | 0.77 | 0.27 | |
| Total vector error | |||
| Translational–systematic | 0.86 | 0.34 | |
| Translational–random | 0.79 | 0.30 | |
| Rotational–systematic | 1.97 | 0.82 | |
| Rotational–random | 1.93 | 0.51 |
Values are average absolute shifts in cm for translational shifts and degree in rotational shifts. P < .05 is considered a statistically significant difference.
Correlation of Total Vector Errors with Body Mass Factors
BMI was significantly correlated with random translational TVE in a weakly positive relationship (B = 0.013; 95% CI, 0.002-0.025; and R2 = 0.119; P = .019). UC was correlated with translational TVE in a weakly positive relationship (B = 0.005; 95% CI, 0.001-0.010; and R2 = 0.090; P = .042). No other significant relationship of translational or rotational TVEs was observed with any of the BMFs (Table 3).
Table 3.
Linear correlation of total vector errors with different body mass factors with regard to systematic and random settings
| Translational shifts |
Rotational shifts |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Setting | B | 95% CI | R2 | P value | B | 95% CI | R2 | -value | ||
| Body mass index | Systematic | 0.009 | –0.005 | 0.022 | 0.037 | .197 | 0.008 | –0.024 | 0.040 | 0.006 | 0.613 |
| Random | 0.013 | 0.002 | 0.025 | 0.119 | .019* | –0.002 | –0.022 | 0.018 | 0.001 | .817 | |
| Umbilical circumference | Systematic | 0.004 | –0.002 | 0.010 | 0.043 | .167 | 0.000 | –0.014 | 0.015 | 0.000 | .944 |
| Random | 0.005 | 0.001 | 0.010 | 0.090 | .042* | –0.005 | –0.014 | 0.004 | 0.026 | .284 | |
| Hip circumference | Systematic | 0.006 | –0.001 | 0.013 | 0.063 | .092 | 0.000 | –0.018 | 0.017 | 0.000 | .969 |
| Random | 0.006 | 0.000 | 0.012 | 0.081 | .055 | –0.006 | –0.017 | 0.005 | 0.025 | .296 | |
| Umbilical anterior–posterior diameter | Systematic | 0.013 | –0.009 | 0.036 | 0.032 | .231 | –0.003 | –0.058 | 0.051 | 0.000 | .911 |
| Random | 0.011 | –0.009 | 0.031 | 0.029 | .260 | –0.022 | –0.055 | 0.012 | 0.037 | .202 | |
| Umbilical lateral diameter | Systematic | 0.011 | –0.008 | 0.030 | 0.032 | .235 | 0.010 | –0.036 | 0.055 | 0.004 | .662 |
| Random | 0.011 | –0.006 | 0.027 | 0.037 | .198 | –0.020 | –0.047 | 0.008 | 0.043 | .165 | |
| Hip anterior–posterior diameter | Systematic | 0.019 | –0.003 | 0.041 | 0.063 | .093 | –0.002 | –0.057 | 0.054 | 0.000 | .950 |
| Random | 0.012 | –0.008 | 0.032 | 0.034 | .219 | –0.006 | –0.041 | 0.029 | 0.003 | .727 | |
| Hip lateral diameter | Systematic | 0.015 | –0.002 | 0.032 | 0.070 | .075 | –0.003 | –0.045 | 0.040 | 0.000 | .899 |
| Random | 0.011 | –0.004 | 0.026 | 0.047 | .148 | –0.017 | –0.043 | 0.009 | 0.038 | .197 | |
Abbreviations: CI, confidence interval; B, unstandardized regression coefficient; R2, Pearson's coefficient; * statistically significant difference (P<.05)
Accuracy Rates and Intercorrelations
By focusing on translational directions, accuracy rates were lower in the lateral and longitudinal directions with respect to the systematic and random settings using both accuracy cutoffs I (≤0.7 cm) and II (≤1.0 cm) compared with the vertical direction. Shifts in the lateral and longitudinal directions were positively correlated with one another, with the strongest correlation (R = 0.574; P < .001) observed in random settings using accuracy cutoff I (Suppl. Material 1).
Association of BMI, UC, and HC With Setup Accuracy in Translational Directions–Pooled Analysis
With respect to the lateral direction, the pooled analysis showed a higher mean BMI in inaccurate setups compared with accurate setups, with a mean difference of approximately 3.50 kg/m2, and was statistically significant using both cutoffs (P = .001). Similarly, measures of UC (mean difference ∼10 cm) and HC (∼8 cm) were significantly higher in inaccurate setups compared with accurate setups (P < .001; Table 4).
Table 4.
Comparison of body mass factors by accuracy level in translational directions (pooled analysis)
| Direction |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lateral |
Longitudinal |
Vertical |
||||||||
| Parameter | Setup accuracy | Mean | SD | P-value | Mean | SD | P-value | Mean | SD | P-value |
| Cutoff I: ≤0.7 cm | ||||||||||
| Body mass index, kg/m2 | Inaccurate | 35.01 | 6.82 | 32.97 | 9.06 | 39.31 | 9.26 | |||
| Accurate | 31.67 | 8.04 | .001* | 31.95 | 7.80 | .330 | 31.91 | 7.86 | .001* | |
| Umbilical circumference, cm | Inaccurate | 109.41 | 14.44 | 101.22 | 18.66 | 116.51 | 17.34 | |||
| Accurate | 100.44 | 16.02 | < .001* | 101.61 | 15.73 | .835 | 101.21 | 15.89 | < .001* | |
| Hip circumference, cm | Inaccurate | 116.75 | 14.01 | 110.79 | 16.23 | 126.26 | 12.64 | |||
| Accurate | 109.73 | 15.08 | < .001* | 110.59 | 14.98 | .918 | 110.23 | 14.97 | < .001* | |
| Cutoff II: ≤1.0 cm | ||||||||||
| Body mass index, kg/m2 | Inaccurate | 35.53 | 5.02 | 31.70 | 8.59 | 35.01 | 5.05 | |||
| Accurate | 31.73 | 8.14 | .001* | 32.11 | 7.90 | .733 | 32.06 | 8.00 | .331 | |
| Umbilical circumference, cm | Inaccurate | 111.18 | 13.70 | 99.49 | 18.86 | 106.94 | 13.11 | |||
| Accurate | 100.54 | 16.00 | < .001* | 101.76 | 15.79 | .336 | 101.54 | 16.13 | .378 | |
| Hip circumference, cm | Inaccurate | 118.15 | 13.05 | 108.61 | 15.99 | 122.24 | 10.81 | |||
| Accurate | 109.81 | 15.12 | < .001* | 110.81 | 15.03 | .322 | 110.50 | 15.12 | .041* | |
Abbreviations: PTV, planning treatment volume; SD, standard deviation
The analysis concerned the pooled data from the first 20 fractions by considering the respective changes in the 3 body mass factors. Setup accuracy is defined regarding the shift value with respect to the used cutoff for the PTV, as follows: Inaccurate setup = shift beyond PTV; accurate = shift within PTV. Test used: Independent t test.
Statistically significant result (P < .05)
With respect to the vertical direction, BMI (mean difference = 7.4 kg/m2; P = .001), UC (5.3 cm; P < .001), and HC (16.0 cm; P < .001) were higher in inaccurate versus accurate setups, but only using cutoff I. When using cutoff II, only HC showed a statistical significance, with a mean difference of 11.7 cm between inaccurate and accurate setups (P = .041; Table 4).
Accuracy of BMI, UC, and HC in Predicting Inaccurate Setup in Lateral and Vertical Plans
The ROC curves are depicted in Figure 1, and the corresponding statistics, as well as the BMI, UC, and HC cutoff calculations with their respective sensitivity and specificity levels, are depicted in Table 5. With respect to cutoff I, BMI was predictive of inaccurate (beyond PTV) setup with an AUC of 0.609 and 0.673 in the lateral and vertical directions, respectively. The corresponding BMI cutoffs were estimated at >30.4 kg/m2 and >31.4 kg/m2, predicting an inaccurate setting in the 2 respective directions with 78.1% and 90.0% sensitivity, respectively. With respect to cutoff II, BMI was predictive beyond PTV setup in the lateral direction with an AUC of 0.680, and a BMI >30.3 kg/m2 was associated with inaccurate settings with 92.5%.
Fig. 1.
Receiver operating characteristics curves of inaccurate setup in translational shifts as a function of body mass factors, including body mass index, umbilical circumference, and hip circumference, with respect to a planning target volume of 0.7 mm in the (A) lateral and (B) vertical directions, and a planning target volume of 7 mm in the (C) lateral direction. The analysis used the pooled data from the first 20 fractions, considering the respective changes in the 3 body mass factors.
Table 5.
Accuracy of pooled setups regarding planning treatment volume as a function of body mass index, umbilical circumference, and hip circumference (receiver operating characteristics curve analysis, cutoffs, and corresponding sensitivity and specificity)
| Direction (setup error cutoff)/predictor | Receiver operating characteristics curve analysis |
Best predictor cutoff |
Diagnostic value |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Area under the curve | Standard error | 95% confidence interval | P-value | Cutoff | Youden's index | Sensitivity | Specificity | ||
| A. Lateral (>0.7 cm) | |||||||||
| BMI, kg/m2 | 0.609 | 0.030 | 0.551 | 0.668 | .001* | 30.4 | 0.222 | 78.1 | 44.1 |
| UC, cm | 0.610 | 0.031 | 0.550 | 0.670 | .001* | 99.5 | 0.215 | 69.8 | 51.7 |
| HC, cm | 0.576 | 0.031 | 0.515 | 0.638 | .019* | 109.9 | 0.161 | 47.4 | 52.6 |
| B. Vertical (>0.7 cm) | |||||||||
| BMI, kg/m2 | 0.673 | .055 | 0.565 | 0.781 | .009* | 31.4 | 0.426 | 90.0 | 52.6 |
| UC, cm | 0.667 | .061 | 0.547 | 0.786 | .011* | 108.9 | 0.268 | 55.0 | 71.8 |
| HC, cm | 0.710 | .053 | 0.606 | 0.814 | .001* | 109.9 | 0.360 | 85.0 | 51.0 |
| C. Lateral (>1.0 cm) | |||||||||
| BMI, kg/m2 | 0.680 | 0.031 | 0.621 | 0.740 | < .001* | 30.3 | 0.347 | 92.5 | 42.3 |
| UC, cm | 0.704 | 0.033 | 0.639 | 0.768 | < .001* | 99.6 | 0.522 | 86.8 | 52.2 |
| HC, cm | 0.654 | 0.036 | 0.583 | 0.725 | < .001* | 109.1 | 0.288 | 77.4 | 51.4 |
Abbreviations: BMI, body mass index; HC, hip circumference; UC, umbilical circumference
The analysis used the pooled data from the first 20 fractions by considering the respective changes in the 3 body mass factors. Test used: Independent t test.
Statistically significant result (P < .05)
The AUCs and cutoffs calculated on UC and HC showed lower sensitivity in indicating inaccurate setting. For all the above-mentioned estimates, specificity was low (up to 52.6%), except for UC in the vertical direction (71.8% for cutoff >108.9 cm).
Effect of Operative Status on Setup Error
There was no difference between intact and operated pelvises with regard to the mean systematic or random setting or TVE in any of the directions (Suppl. Material 2). However, in the pooled analysis, accuracy rates in the longitudinal direction were lower in intact versus operated patients, using both ≤0.7 cm (79.0% vs 85.3%; P = .017) and ≤1.0 cm (89.8% vs 94.9%; P = .005) cutoffs, respectively (Suppl. Material 3).
Discussion
Key Observations
The present study tested the effect of 3 BMFs on the magnitude of setup errors in female patients treated with VMAT, with or without surgery, for endometrial or cervix malignancy. The greatest displacements were observed in the lateral and longitudinal directions. Shift magnitudes in the lateral and longitudinal directions were correlated with one another when considering both the systemic and random settings. Although the accuracy rates in the lateral and longitudinal plans were correlated with one another, the association between setup accuracy and BMFs was significant in the lateral, but not the longitudinal, direction. In the vertical direction, although setups were highly accurate (92.8% using cutoff I; 98.6% using cutoff II), the variance in setup error was significantly associated with BMI, UC, and HC with respect to cutoff I, but not cutoff II. BMI was the most accurate indicator for setup inaccuracy.
Radiation Therapy Setup Errors in Gynecologic Tumors
Findings from the present study show that patients treated with VMAT for gynecologic tumors are subject to great setup errors in the translational direction, both in the systematic and random settings. Most remarkably, the shift's magnitude was significant in the lateral and longitudinal directions, showing the lowest accuracy notably using a PTV margin of 0.7 cm (cutoff I ≤ 0.7 cm), where the accuracy rates were 77.6% and 77.5%, respectively. Of note, with automatic couch adjustment after cone beam CT, patients were all treated within the PTV. On the other hand, setup error was remarkably low in the vertical direction.
These setup variations in patients treated for gynecologic tumors are due to the large motion of pelvic organs, both during inter- and intrafraction times.15 Furthermore, the data demonstrated that the magnitude of the shift depends on the organ, because uterine motion is larger than cervix motion as one would expect conforming to the anatomic features of each organ,16,17 would have significant effect on the definition of RT target volumes. Comparing setup errors between patients with cervix versus endometrial cancer was beyond the scope of the study.
Several authors were concerned with the frequency and magnitude of setup errors in gynecologic tumors. However, the differential magnitude between the directions varied between the studies. For instance, Haslam et al. observed an average setup error ranging from 0.19 to 0.26 mm in systematic and 0.26 to 0.37 cm in random settings, and the error magnitude was the greatest in the anterior–posterior (vertical) direction.18 Similarly, Laursen et al. found the greatest setup error (0.36 mm) in the anterior–posterior direction with a CTV-PTV margin as high as 1.16 cm versus 0.82 and 0.96 cm in the superior–inferior and mediolateral direcdtions, respectively.19
Santanam et al. found average setup errors ranging from 0.15 to 0.46 mm in systematic settings and from 0.31 to 0.48 in random settings, and the superior-inferior direction entailed the greatest displacement with a CTV-PTV margin as high as 0.94 cm, compared with 0.72 and 0.67 cm in the anterior-posterior and mediolateral, respectively (20). Therefore, determining the treatment margins that encompass these setup errors while sparing normal tissue is critical. However, there is no consensus regarding the margins of the PTV to be used in patients with gynecologic cancers.19, 20, 21, 22 Repeated cone beam CT imaging remains a precious tool to enhance the precision of treatment targeting.12
Effect of Body Mass Factors on Translational Shifts
The present study demonstrated the significant contribution of BMFs, including BMI, UC, and HC, in enlarging setup errors in the translational direction among patients treated for cervical and endometrial cancers. Since the authors observed that setup errors were of greater magnitude and variance in the lateral and longitudinal directions and significantly correlated with one another, they hypothesized that such a variance may be explained by the variance in BMI and other BMFs. However, the effect of BMFs was only significant in the lateral direction, but not the longitudinal direction, which indicates that BMI, UC, and HC account for the magnitude and variance of the setup errors in the lateral direction, but they do not affect setup errors in the longitudinal direction. Also, setup errors in the vertical direction were proportional to BMI, UC, and HC with respect to cutoff I, but not cutoff II, although settings in this direction were highly accurate (92.8% using cutoff I; 98.6% using cutoff II).
The effect of BMI and other BMFs on the magnitude of setup errors was demonstrated in gynecologic tumors, and probably contributes to the unfavorable outcomes in obese patients.23 In agreement with the study findings, Lin et al. reported a gradual increase in translational setup errors in patients treated for endometrial malignancy as a function of the BMI category. On the other hand, the authors did not observe a significant correlation between BMI category and rotational shifts. By using the median BMI, the authors found that BMI ≥30 kg/m2 increased the percentage of patients who would require a +0.7 cm margin shift from 11% to 28% in the vertical, 5% to 15% in the longitudinal, and 6% to 25% in the lateral direction, with reference to BMI <30kg/m2.11
Similarly, Kim et al. analyzed the effect of BMI on setup errors in the 3 translational directions among 52 women with different gynecologic cancers, including cancer of the endometrium, cervix, and vulva. The results demonstrated that patients with BMI ≥30kg/m2 had a greater CTV-to-PTV margin, notably in the medial–lateral direction (10.3 vs 7.3 mm), compared with those who had a BMI <30 kg/m2. Furthermore, the authors reported that the proportion of patients with a shift ≥0.5 cm was greater in the high-BMI subgroup (62%) compared with the normal-BMI group (48%).24 Likewise, Bray et al. demonstrated that patients with BMI ≥30 kg/m2 displayed a greater composite shift in the translational direction (8.0 ± 5.8 mm) compared with those with BMI <30 kg/m2 (5.5 ± 3.2 mm), and BMI explained 57% of the variance of the shift in the right–left direction. The authors concluded on the importance of daily image guided RT for obese patients to reduce imprecision in dose and volume delivery.25
On the other hand, few studies failed to demonstrate such an effect of BMFs on setup errors. For example, Haslam et al. observed no statistically significant effect of BMI, weight, or height on setup errors in a sample of participants composed of 15 normal-weighted, 12 overweight, and 15 obese patients.18 The variability of the effect between the studies may be affected by the considered BMF, in addition to several technical and methodological factors, such as the sampling methods, immobilization technique, and/or characteristics of the population, notably the organ and operative status.
Considering Body Mass Factors in Defining Shift Margin
Altogether, these data demonstrate the relevance of considering further adjustment for organ displacement in obese patients, which may have an effect, not only on the efficacy, but also the safety of RT. Amini et al. demonstrated that a patient with BMI ≥30kg/m2 had a 5-fold risk of having a translational shift ≥0.7 cm, showing the necessity of increasing the PTV for such patients beyond the 0.7 cm standard.9
Interestingly, Yavas et al. explored the association of BMI with both PTV and organ-at-risk volumes in patients with early stage endometrial cancer who were treated with adjuvant RT subsequent to a total hysterectomy. The analysis focused on comparing field-in-field RT to 3-dimensional conformal RT in terms of precision of treatment delivery. Although the authors reported a positive relationship of BMI with PTV and mean irradiation doses received by the organs at risk, field in field was observed to significantly reduce the organ-at-risk volumes in obese patients, notably for those with bowel, bladder, and bone marrow cancer.26
Furthermore, what applied to gynecologic cancers applied also for other pelvic cancers. Wu et al. explored the relationship of different BMFs with setup errors in patients treated for rectum, prostate, and gynecologic cancers. The authors found a positive linear relationship between UC and systematic and random setup errors in the translational direction, which was stronger in the mediolateral direction irrespective of the organ.13
Body Mass Index Was the Most Accurate Indicator for Setup Inaccuracy
The particularity of the present study was the determination of BMI, UC, and HC cutoffs based on the ROC curve analysis, but most other studies used an arbitrary cutoff of ≥ 30kg/m2.11,24,25 Despite using a different method, the study analysis showed a similar cutoff value, because a BMI >30.3 kg/m2 was predictive for inaccurate setup (shift >1.0 cm) in the lateral direction with 92.5% sensitivity, which corresponds to the obese category defined by the World Health Organization classification.27 Moreover, a BMI >31.4 kg/m2 was predictive for an inaccurate setup (shift >0.7 cm) in the vertical direction with 90% sensitivity. However, both cutoffs had low specificity (<45%).
On the other hand, UC and HC showed lower sensitivities compared with BMI, indicating lesser interest in predicting setup errors. Plausibly, some BMFs may have a greater effect on setup errors than others, and the differential effect may vary depending on other patient-related factors. However, as suggested by Wu et al.,13 any eventual consensus concerned with adapting the PTV-CTV margin for obese patients should consider establishing a scoring system using multiple BMFs. However, the utility of daily cone beam CT in obese patients has been widely adopted to quantify geometric uncertainties in treatment rather than adapting PTV margins.
Additionally, cone beam CT can help evaluate possible weight loss and change in tumor size that may require treatment replanning. Therefore, daily cone beam CT may be necessary for this category of patients, but may entail longer treatment times, as well as increased cost and patient exposure to higher radiation doses, notably to adjacent organs, such as the rectum.13 To mitigate such a risk, cone beam CT scans can be optimized by using low-dose cone beam CT scans, which provide comparable image quality, as suggested by Ordóñez-Sanz et al. who presented a simple method to develop pelvis cone beam CT imaging protocols based on patient size to reduce concomitant imaging doses.28
Limitations
The main limitation this study is the skewed distribution in BMI, because the majority of participants were overweight or obese, which is possibly due to a high prevalence of obesity in the target population rather than selection bias, because the authors included consecutive patients. Nevertheless, this probably affected the validity of the correlation and cutoff sensitivity (ROC curve) analyses. A BMI-stratified sampling method may provide a more accurate analysis, but may require a higher patient flow.
Conclusions
The present study demonstrated a significant contribution of BMFs, including BMI, UC, and HC, to enlarging setup errors in the translational direction among patients treated for cervical and endometrial cancers. All 3 BMFs showed a significant effect on setup errors, but BMI was more sensitive in predicting a vertical shift >0.7 cm and a lateral shift >1.0 cm, and the determined cutoff corresponds to the World Health Organization obesity threshold. In the absence of a consensus regarding the adaptation of PTV-CTV margins for obese patients, further data are required to determine the optimal frequency of image guided RT to minimize setup uncertainty in such patients. The clinical interest of daily cone beam CT in obese patients, weighed with the resulting high-radiation exposure, indicates the need to consider low-dose cone beam CT protocols in this category of patients. Additionally, further research efforts are warranted to explore the effects of different BMFs and the possibility of establishing a weighed score.
Acknowledgments
The authors acknowledge Dr Mohamed Amine Haireche for his help with the statistical analysis of this study.
Footnotes
Sources of support: This work had no specific funding.
Disclosures: None.
Data sharing statement for this Work: Research data are stored in an institutional repository, and will be shared upon request to the corresponding author.
Supplementary material associated with this article can be found in the online version at doi:10.1016/j.adro.2022.101108.
Appendix. Supplementary materials
References
- 1.Bazarbashi S, Eid H, Minguet J. Cancer incidence in Saudi Arabia: 2012 data from the Saudi Cancer Registry. Asian Pac J Cancer Prev. 2017;18:2437–2444. doi: 10.22034/APJCP.2017.18.9.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 3.Klopp A, Smith BD, Alektiar K, et al. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014;4:137–144. doi: 10.1016/j.prro.2014.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol. 2015;41:975–985. doi: 10.1016/j.ejso.2015.03.235. [DOI] [PubMed] [Google Scholar]
- 5.Malicki J. The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother. 2012;17:63–65. doi: 10.1016/j.rpor.2012.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Small W, Bosch WR, Harkenrider MM, et al. NRG Oncology/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer: An update. Int J Radiat Oncol Biol Phys. 2021;109:413–424. doi: 10.1016/j.ijrobp.2020.08.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mulla Z, Hashem RM, Almohamad A, et al. A comparison between two different immobilization devices for radiation therapy treatment of pelvic cancer using VMAT. J Med Imaging Radiat Sci. 2021;52:238–247. doi: 10.1016/j.jmir.2021.02.008. [DOI] [PubMed] [Google Scholar]
- 8.Winters E, Poole C. Challenges and impact of patient obesity in radiation therapy practice. Radiography. 2020;26:e158–e163. doi: 10.1016/j.radi.2020.01.005. [DOI] [PubMed] [Google Scholar]
- 9.Amini A, DeWitt PE, Vinogradskiy Y, et al. Should we customize PTV expansions for BMI? Daily cone beam computerized tomography to assess organ motion in postoperative endometrial and cervical cancer patients. Rep Pract Oncol Radiother. 2016;21:195–200. doi: 10.1016/j.rpor.2016.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Malyapa RS, Chao KS, Williamson JF, Grigsby PW. Pelvic organ motion and displacement during radiation therapy in patients with gynecological malignancies–A prospective study using serial CT imaging during external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2001;51:218. [Google Scholar]
- 11.Lin LL, Hertan L, Rengan R, Teo BKK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys. 2012;83:670–675. doi: 10.1016/j.ijrobp.2011.07.026. [DOI] [PubMed] [Google Scholar]
- 12.Patni N, Burela N, Pasricha R, et al. Assessment of three-dimensional setup errors in image-guided pelvic radiotherapy for uterine and cervical cancer using kilovoltage cone-beam computed tomography and its effect on planning target volume margins. J Cancer Res Ther. 2017;13:131. doi: 10.4103/0973-1482.199451. [DOI] [PubMed] [Google Scholar]
- 13.Wu WC, Chang YR, Lai YL, et al. Impact of body-mass factors on setup displacement during pelvic irradiation in patients with lower abdominal cancer. Radiol Oncol. 2019;53:256–264. doi: 10.2478/raon-2019-0017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Akuamoa-Boateng D, Wegen S, Ferdinandus J, Marksteder R, Baues C, Marnitz S. Managing patient flows in radiation oncology during the COVID-19 pandemic: Reworking existing treatment designs to prevent infections at a German hot spot area University Hospital. Strahlenther Onkol. 2020;196:1080–1085. doi: 10.1007/s00066-020-01698-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chan P, Dinniwell R, Haider MA, et al. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: A cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys. 2008;70:1507–1515. doi: 10.1016/j.ijrobp.2007.08.055. [DOI] [PubMed] [Google Scholar]
- 16.Collen C, Engels B, Duchateau M, et al. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010;77:1590–1595. doi: 10.1016/j.ijrobp.2009.10.021. [DOI] [PubMed] [Google Scholar]
- 17.Taylor A, Powell MEB. An assessment of interfractional uterine and cervical motion: Implications for radiotherapy target volume definition in gynaecological cancer. Radiother Oncol. 2008;88:250–257. doi: 10.1016/j.radonc.2008.04.016. [DOI] [PubMed] [Google Scholar]
- 18.Haslam JJ, Lujan AE, Mundt AJ, Bonta DV, Roeske JC. Setup errors in patients treated with intensity-modulated whole pelvic radiation therapy for gynecological malignancies. Med Dosim. 2005;30:36–42. doi: 10.1016/j.meddos.2004.10.007. [DOI] [PubMed] [Google Scholar]
- 19.Laursen LV, Elstrøm UV, Vestergaard A, et al. Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer. Radiother Oncol. 2012;105:220–225. doi: 10.1016/j.radonc.2012.08.012. [DOI] [PubMed] [Google Scholar]
- 20.Santanam L, Esthappan J, Mutic S, et al. Estimation of setup uncertainty using planar and mvct imaging for gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2008;71:1511–1517. doi: 10.1016/j.ijrobp.2008.03.070. [DOI] [PubMed] [Google Scholar]
- 21.Stromberger C, Gruen A, Wlodarczyk W, Budach V, Koehler C, Marnitz S. Optimizing image guidance frequency and implications on margins for gynecologic malignancies. Radiat Oncol. 2013;8:110. doi: 10.1186/1748-717X-8-110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lim K, Kelly V, Stewart J, et al. Pelvic radiotherapy for cancer of the cervix: Is what you plan actually what you deliver? Int J Radiat Oncol Biol Phys. 2009;74:304–312. doi: 10.1016/j.ijrobp.2008.12.043. [DOI] [PubMed] [Google Scholar]
- 23.Feng YH. The association between obesity and gynecological cancer. Gynecol Minim Invasive Ther. 2015;4:102–105. [Google Scholar]
- 24.Kim H, Beriwal S, Huq MS, Kannan N, Shukla G, Houser C. Evaluation of set-up uncertainties with daily kilovoltage image guidance in external beam radiation therapy for gynaecological cancers. Clin Oncol. 2012;24:e39–e45. doi: 10.1016/j.clon.2011.09.007. [DOI] [PubMed] [Google Scholar]
- 25.Bray TS, Kaczynski A, Albuquerque K, Cozzi F, Roeske JC. Role of image guided radiation therapy in obese patients with gynecologic malignancies. Pract Radiat Oncol. 2013;3:249–255. doi: 10.1016/j.prro.2012.09.001. [DOI] [PubMed] [Google Scholar]
- 26.Yavas G, Yavas C, Kerimoglu OS, Celik C. The impact of body mass index on radiotherapy technique in patients with early stage endometrial cancer: A single-center dosimetric study. Int J Gynecol Cancer. 2014;24:1607–1615. doi: 10.1097/IGC.0000000000000298. [DOI] [PubMed] [Google Scholar]
- 27.Weir CB, Jan A. StatPearls Publishing; Treasure Island, FL: 2022. BMI classification percentile and cutoff points. [PubMed] [Google Scholar]
- 28.Ordóñez-Sanz C, Cowen M, Shiravand N, MacDougall ND. CBCT imaging: A simple approach for optimising and evaluating concomitant imaging doses, based on patient-specific attenuation, during radiotherapy pelvis treatment. Br J Radiol. 2021;94 doi: 10.1259/bjr.20210068. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

